Connect with us
  • tg

Stock Markets

AptarGroup director Giovanna Kampouri Monnas sells shares worth over $277k

letizo News

Published

on

In a recent transaction, Giovanna Kampouri Monnas, a director at AptarGroup, Inc. (NYSE:), sold 1,922 shares of the company’s common stock, generating over $277,000. The sale occurred on August 13, with the weighted average price per share being $144.4342. The transactions took place at prices ranging from $144.2800 to $144.5100.

Following the sale, Kampouri Monnas’s ownership in AptarGroup decreased, leaving her with a total of 8,839 shares held directly. The sale was made public through a Form 4 filing with the Securities and Exchange Commission, which was dated August 14.

AptarGroup, Inc., headquartered in Crystal Lake, Illinois, is known for its diverse range of dispensing systems and packaging solutions, serving the pharmaceutical, beauty, home, and food and beverage sectors. The company’s shares are traded on the New York Stock Exchange under the ticker symbol ATR.

Investors often monitor the buying and selling activities of a company’s directors and executives as they may provide insights into the company’s financial health and future prospects. However, such transactions can occur for various personal or financial reasons and do not always indicate a change in the company’s outlook.

The detailed transactions and the subsequent ownership information are available to the public and can be requested from the SEC staff, the issuer, or a security holder of the issuer, as per the undertakings in the Form 4 filing.

In other recent news, Aptar has reported a robust growth in its second quarter of 2024, with a 3% increase in core sales and a 12% rise in adjusted earnings per share (EPS). The company’s impressive performance is largely attributed to the high demand for its proprietary pharma drug delivery systems and improving margins. Aptar’s pharma segment saw a 7% increase in core sales, while the beauty segment experienced a decline due to weaker sales in Europe.

On the financial front, Aptar’s Q2 capital expenditures were approximately $68 million, predominantly allocated to the Pharma segment. The company anticipates this growth to continue into the third quarter, projecting an adjusted EPS between $1.38 and $1.46 per share.

Despite the strong performance, Aptar encountered some challenges, including higher corporate expenses and a decrease in the beauty segment’s core sales due to lower demand in Europe. However, the company maintains a robust balance sheet, with a leverage ratio of approximately 1.3, which is expected to support ongoing investments and strategic opportunities. The company also expressed confidence in the continuation of earnings growth, with no significant changes in the competitive landscape anticipated.

InvestingPro Insights

Amid the recent sale of shares by director Giovanna Kampouri Monnas, AptarGroup, Inc. (NYSE:ATR) continues to display a stable financial outlook according to the latest metrics. With a market capitalization of approximately $9.55 billion and a Price/Earnings (P/E) ratio of 29.63, the company stands out in its industry. The adjusted P/E ratio for the last twelve months as of Q2 2024 is slightly lower at 26.82, indicating a more favorable valuation when considering the company’s earnings over the past year.

Investors tracking the company’s performance will note that AptarGroup has maintained a consistent revenue growth, with a 4.96% increase over the last twelve months as of Q2 2024. This steady growth is complemented by a solid gross profit margin of 36.94%, showcasing the company’s effectiveness in managing its cost of goods sold and maintaining profitability.

An InvestingPro Tip worth noting is that AptarGroup has a commendable track record of raising its dividend, with 32 consecutive years of consistent payouts. This reflects the company’s commitment to returning value to shareholders and its confidence in sustained financial health. Additionally, analysts are optimistic about the company’s future, having revised their earnings upwards for the upcoming period. This could signal a positive outlook for the company’s financial performance moving forward.

For investors seeking more in-depth analysis, there are additional InvestingPro Tips available on the company’s profile at https://www.investing.com/pro/ATR. These tips provide valuable insights that can help investors make informed decisions about their investments in AptarGroup.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Stock Markets

Israeli strikes kill dozens in Gaza over 48 hours, Palestinian officials say

letizo News

Published

on

By Nidal al-Mughrabi

CAIRO (Reuters) -Israeli military strikes across the Gaza Strip have killed at least 120 Palestinians over the last 48 hours and hit a hospital on the northern edge of the enclave, wounding medical staff and damaging equipment, Palestinian medics said on Saturday.

Among the dead were seven members of one family whose house was hit overnight in the Zeitoun suburb of Gaza City, the health officials said. The rest were killed in separate Israeli strikes in central and southern Gaza.

At the same time, Israeli forces deepened their incursion and bombardment of the northern edge of the enclave, their main offensive since early last month.

A spokesperson for the armed wing of Hamas said a female Israeli hostage in the group’s custody had been killed in a northern area under attack by Israeli forces.

“The life of another female prisoner who used to be with her remains in imminent danger,” spokesperson Abu Ubaida added, accusing the government of Israeli Prime Minister Benjamin Netanyahu of being to blame.

An Israeli military spokesperson said it was investigating the Hamas report.

“At this point, we are unable to confirm or deny it,” the spokesperson said. “Hamas continues to engage in psychological terrorism and act in a cruel manner.”

A group representing hostages’ families did not immediately reply to a request for comment.

DAMAGE, INJURIES AT HOSPITAL

Israel’s military says its operations in northern Gaza aim to prevent Hamas fighters from carrying out attacks and regrouping. Local residents say they fear the goal is to permanently depopulate a strip of territory as a buffer zone, something Israel denies.

At Kamal Adwan Hospital, one of three medical facilities on the northern edge of Gaza that is barely operational, director Hussam Abu Safiya said the ongoing Israeli bombardment in the area appeared aimed at forcing hospital staff to evacuate – something they have refused to do since the incursion began.

“Yesterday (Friday), from the afternoon until midnight, the bombardment directly targeted the entrance to the emergency and reception area several times,” he said in a statement, adding that 12 staff members including doctors and nurses were injured.

The strike also caused significant damage that disrupted the electrical generator, oxygen supply network and water supply, he added.

Asked to comment on Abu Safiya’s statement, the Israeli military said that following an initial review it was “not aware of a strike in the area of the Kamal Adwan Hospital”, adding that it does everything possible to avoid harming civilians.

Israel says Hamas uses hospitals and civilians as human shields, and has made public videos and photos to support that claim. Hamas rejects the allegations and says it does not use the civilian population or facilities for military purposes.

Israel’s 13-month campaign in Gaza has killed more than 44,000 people and displaced nearly all the enclave’s population at least once, according to Gaza officials.

The war was launched in response to an attack by Hamas-led fighters who killed 1,200 people and captured more than 250 hostages in Israel on Oct. 7, 2023, Israel has said.

© Reuters. A Palestinian man inspects a house hit in an Israeli strike, amid the ongoing conflict between Israel and Hamas, in Gaza City November 21, 2024. REUTERS/Mahmoud Issa

Months of attempts to negotiate a ceasefire have yielded scant progress and negotiations are now on hold, with mediator Qatar having suspended its efforts until the sides are prepared to make concessions.

Hamas wants a deal that ends the conflict, and leads to the release of Israeli and foreign hostages held captive in Gaza as well as Palestinians jailed by Israel, while Netanyahu has said the war can end only once Hamas is eradicated.

Continue Reading

Stock Markets

Trump expected to pick Brooke Rollins to be agriculture secretary, WSJ reports

letizo News

Published

on

WASHINGTON (Reuters) -U.S. President-elect Donald Trump is expected to pick Brooke Rollins (NYSE:), president of the America First Policy Institute, to be agriculture secretary, the Wall Street Journal reported on Saturday.

If confirmed, Rollins would lead a 100,000-person agency with offices in every county in the country, whose remit includes farm and nutrition programs, forestry, home and farm lending, food safety, rural development, agricultural research, trade and more. It had a budget of $437.2 billion in 2024.

Trump’s transition team did not immediately respond to a request for comment.

The nominee’s agenda would carry implications for American diets and wallets, both urban and rural. Department of Agriculture officials and staff negotiate trade deals, guide dietary recommendations, inspect meat, fight wildfires and support rural broadband, among other activities.

The America First Policy Institute is a right-leaning think tank whose personnel have worked closely with Trump’s campaign to help shape policy for his incoming administration. She chaired the Domestic Policy Council during Trump’s first term.

If confirmed, Rollins would advise the administration on how and whether to implement clean fuel tax credits for biofuels at a time when the sector is hoping to grow through the production of sustainable aviation fuel.

The nominee would also guide next year’s renegotiation of the U.S.-Mexico-Canada trade deal, in the shadow of disputes over Mexico’s attempt to bar imports of genetically modified corn and Canada’s dairy import quotas.

© Reuters. Brooke Rollins, President and CEO of the America First Policy Institute speaks during a rally for Republican presidential nominee and former U.S. President Donald Trump at Madison Square Garden, in New York, U.S., October 27, 2024. REUTERS/Andrew Kelly/File Photo

Trump has said he again plans to institute sweeping tariffs that are likely to affect the farm sector.

He was considering offering the role to former U.S. Senator Kelly Loeffler, a staunch ally whom he chose to co-chair his inaugural committee, CNN reported on Friday.

Continue Reading

Stock Markets

ICC warrants are binding, EU cannot pick and choose, EU’s Borrell says

letizo News

Published

on

By Michele Kambas

NICOSIA (Reuters) – European Union governments cannot pick and choose whether to execute arrest warrants issued by the International Criminal Court against two Israeli leaders and a Hamas commander, the EU’s foreign policy chief said on Saturday.

The ICC issued the warrants on Thursday against Israeli Prime Minister Benjamin Netanyahu, his former defence minister Yoav Gallant and Hamas leader Ibrahim Al-Masri, for alleged crimes against humanity.

All EU member states are signatories to the ICC’s founding treaty, called the Rome Statute.

Several EU states have said they will meet their commitments under the statute if needed, but Hungarian Prime Minister Viktor Orban has invited Netanyahu to visit his country, assuring him he would face no risks if he did so.

“The states that signed the Rome convention are obliged to implement the decision of the court. It’s not optional,” Josep Borrell, the EU’s top diplomat, said during a visit to Cyprus for a workshop of Israeli and Palestinian peace activists.

Those same obligations were also binding on countries aspiring to join the EU, he said.

“It would be very funny that the newcomers have an obligation that current members don’t fulfil,” he told Reuters.

The United States rejected the ICC’s decision and Israel said the ICC move was antisemitic.

“Every time someone disagrees with the policy of one Israeli government – (they are) being accused of antisemitism,” said Borrell, whose term as EU foreign policy chief ends this month.

“I have the right to criticise the decisions of the Israeli government, be it Mr Netanyahu or someone else, without being accused of antisemitism. This is not acceptable. That’s enough.”

Israel’s 13-month campaign in Gaza has killed about 44,000 Palestinians and displaced nearly all the enclave’s population while creating a humanitarian crisis, Gaza officials say.

Israel began its offensive after the Hamas-led attack on Oct. 7, 2023, which killed 1,200 people in southern Israel, with more than 250 others taken hostage, Israel has said.

© Reuters. Israeli Prime Minister Benjamin Netanyahu speaks at the plenum, during a discussion on the subject of hostages kidnapped during the deadly October 7, 2023 attack, in Israel's parliament, the Knesset, in Jerusalem, November 18, 2024. REUTERS/Ronen Zvulun/

In their decision, the ICC judges said there were reasonable grounds to believe Netanyahu and Gallant were criminally responsible for acts including murder, persecution and starvation as a weapon of war as part of a “widespread and systematic attack against the civilian population of Gaza”.

The warrant for Masri lists charges of mass killings during the Oct. 7, 2023, attacks. Israel says it has killed Masri.

Continue Reading

Trending

©2021-2024 Letizo All Rights Reserved